|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 14/725 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 35/17 | (2015.01) |
| (11) | Number of the document | 3749338 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20741851.8 |
| Date of filing the European patent application | 2020-01-15 | |
| (97) | Date of publication of the European application | 2020-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-17 |
| (46) | Date of publication of the claims translation | 2024-08-12 |
| (86) | Number | PCT/US2020/013662 |
| Date | 2020-01-15 |
| (87) | Number | WO 2020/150339 |
| Date | 2020-07-23 |
| (30) | Number | Date | Country code |
| 201962793274 P | 2019-01-16 | US |
| (72) |
WU, Lijun , US
GOLUBOVSKAYA, Vita , US
|
| (73) |
Caribou Biosciences, Inc. ,
2929 7th Street
Suite 105, Berkeley, CA 94710,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Humanizuoti BCMA antikūnai ir BCMA-CAR-T ląstelės |
| HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS |
| Payment date | Validity (years) | Amount | |
| 2025-12-18 | 7 | 162.00 EUR |
| 2027-01-15 |